The FDA has, for the first time, cleared a specific kind of cell therapy for human testing in epilepsy, backing an allogeneic GABA‑producing cell therapy…
March 16, 2026
Magdalena Biosciences, the Jaguar Health–Filament Health JV, has begun preclinical tests of coca-based appetite suppressants.
Magdalena Biosciences, a joint venture between Jaguar Health, Inc. (NASDAQ: JAGX) and Filament Health Corp. (OTC: FLHLF), has initiated a preclinical study evaluating whole-leaf coca…
Shares of CXApp Inc. (NASDAQ: CXAI) are climbing sharply today, up roughly 30% as traders respond to fresh news that the company has secured an additional 180‑day extension…
March 11, 2026
Envoy Medical Completes Enrollment for Pivotal Trial of Fully Implanted Cochlear Implant
Envoy Medical, Inc. (NASDAQ: COCH) has completed patient enrollment in its pivotal clinical trial evaluating the investigational Acclaim fully implanted cochlear implant. This milestone moves…
Shares of Longeveron Inc. (ticker: LGVN) are ripping higher today, with the stock recently up about 71% as traders react to a string of positive stem‑cell trial updates and fresh…
Kymera Therapeutics, Inc. (NASDAQ: KYMR) presented new clinical data for KT-621, its investigational oral therapy for inflammatory diseases, during the American Academy of Dermatology (AAD)…
March 10, 2026
HeartBeam and Mount Sinai Launch AI Collaboration to Advance Remote Cardiac Monitoring
HeartBeam, Inc. (NASDAQ: BEAT) has announced a strategic collaboration with the Icahn School of Medicine at Mount Sinai to develop artificial intelligence–powered ECG algorithms designed…
Novo Nordisk (NYSE: NVO) has reached an agreement with Hims & Hers Health, Inc. (NYSE: HIMS) that will allow the telehealth company to distribute Novo…
Caris Life Sciences (NASDAQ: CAI) has introduced a new Caris AI Insights molecular signature designed to help physicians select the most effective first-line treatment for…
Shares of Xenon Pharmaceuticals Inc. (NASDAQ: XENE) jumped sharply after the company reported positive results from its Phase 3 clinical trial evaluating azetukalner, an investigational…
March 06, 2026
MiniMed Prices Initial Public Offering as Medtronic Diabetes Unit Prepares to Trade Independently
MiniMed, the diabetes technology business being separated from Medtronic plc, has announced the pricing of its initial public offering (IPO) as it prepares to begin…
March 05, 2026
Airiver Medical Wins FDA Breakthrough Device Status for Pulmonary Drug Coated Balloon to Treat Central Airway Stenosis
Airiver Medical has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its pulmonary drug-coated balloon (DCB) designed to treat central…